Ribosomal protein S27L is a direct p53 target that regulates apoptosis

He, H.; Sun, Y.
April 2007
Oncogene;4/26/2007, Vol. 26 Issue 19, p2707
Academic Journal
Ribosomal proteins were recently shown to regulate p53 activity by abrogating Mdm2-induced p53 degradation (L23, L11, L5) or by enhancing p53 translation (L26). Here, we report that a novel ribosomal protein, RPS27L (S27-like protein), is a direct p53 target. RPS27L, but not its family member RPS27, was identified as a p53 inducible gene in a genome-wide chip-profiling study. Further characterization revealed a p53-dependent induction of RPS27L in multiple cancer cell models. Indeed, a consensus p53-binding site was identified in the first intron of the RPS27L gene and a direct binding of p53 to this site was demonstrated both in vitro and in vivo. Characterization of a luciferase reporter driven by the RPS27L intron fragment revealed a p53-binding site-dependent transaction by wild-type p53, but not by several transactivating-deficient p53 mutants. This transactivation was enhanced by etoposide, a DNA damaging agent that activates p53 and was completely blocked by a dominant-negative p53 mutant. Functionally, overexpression of RPS27L within the physiological inducible levels promoted, whereas siRNA silencing of RPS27L inhibited, apoptosis induced by etoposide. This is the first report, to our knowledge, that p53 directly induces the expression of a ribosomal protein, RPS27L, which in turn promotes apoptosis.Oncogene (2007) 26, 2707–2716. doi:10.1038/sj.onc.1210073; published online 23 October 2006


Related Articles

  • PRIMA-1MET/APR-246 targets mutant forms of p53 family members p63 and p73. Rökaeus, N; Shen, J; Eckhardt, I; Bykov, V J N; Wiman, K G; Wilhelm, M T // Oncogene;12/9/2010, Vol. 29 Issue 49, p6442 

    The low molecular weight compound PRIMA-1 and the structural analog PRIMA-1MET, also named APR-246, reactivate mutant p53 through covalent binding to the core domain and induce apoptosis in tumor cells. Here, we asked whether PRIMA-1MET/APR-246 can rescue mutant forms of the p53 family members...

  • TAF6δ orchestrates an apoptotic transcriptome profile and interacts functionally with p53. Wilhelm, Emmanuelle; Kornete, Mara; Targat, Brice; Vigneault-Edwards, Jimmy; Frontini, Mattia; Tora, Laszlo; Benecke, Arndt; Bell, Brendan // BMC Molecular Biology;2010, Vol. 11, p1 

    Background: TFIID is a multiprotein complex that plays a pivotal role in the regulation of RNA polymerase II (Pol II) transcription owing to its core promoter recognition and co-activator functions. TAF6 is a core TFIID subunit whose splice variants include the major TAF6α isoform that is...

  • Disorder and residual helicity alter p53-Mdm2 binding affinity and signaling in cells. Borcherds, Wade; Theillet, François-Xavier; Katzer, Andrea; Finzel, Ana; Mishall, Katie M; Powell, Anne T; Wu, Hongwei; Manieri, Wanda; Dieterich, Christoph; Selenko, Philipp; Loewer, Alexander; Daughdrill, Gary W // Nature Chemical Biology;Dec2014, Vol. 10 Issue 12, p1000 

    Levels of residual structure in disordered interaction domains determine in vitro binding affinities, but whether they exert similar roles in cells is not known. Here, we show that increasing residual p53 helicity results in stronger Mdm2 binding, altered p53 dynamics, impaired target gene...

  • CP-31398, a novel p53-stabilizing agent, induces p53-dependent and p53-independent glioma cell death. Wischlmsen, J.; Naumann, U.; Ohgaki, H.; Rastinejad, F.; Weller, M. // Oncogene;11/13/2003, Vol. 22 Issue 51, p8233 

    CP-31398 is a prototype small molecule that stabilizes the active conformation of p53 and promotes p53 activity in cancer cell lines with mutant or wild-type p53. Here, we report that CP-31398 induces p53 reporter gene activity and p21 expression in all of 11 glioma cell lines harboring...

  • Transcriptional analysis of immune-related gene expression in p53-deficient mice with increased susceptibility to influenza A virus infection. Wenjun Yan; Jianchao Wei; Xufang Deng; Zixue Shi; Zixiang Zhu; Donghua Shao; Beibei Li; Shaohui Wang; Guangzhi Tong; Zhiyong Ma // BMC Medical Genomics;Aug2015, Vol. 8 Issue 1, p1 

    Background: p53 is a tumor suppressor that contributes to the host immune response against viral infections in addition to its well-established protective role against cancer development. In response to influenza A virus (IAV) infection, p53 is activated and plays an essential role in inhibiting...

  • p53 Increases Intra-Cellular Calcium Release by Transcriptional Regulation of Calcium Channel TRPC6 in GaQ3-Treated Cancer Cells. Madan, Esha; Gogna, Rajan; Keppler, Bernhard; Pati, Uttam // PLoS ONE;Aug2013, Vol. 8 Issue 8, p1 

    p53 and calcium signaling are inter-dependent and are known to show both synergistic and antagonistic effects on each other in the cellular environment. However, no molecular mechanism or cellular pathway is known which shows direct regulation between these important cellular signaling...

  • Deacetylase recruitment by the C/H3 domain of the acetyltransferase p300. Simone, Cristiano; Stiegler, Peter; Forcales, Sonia-Vanina; Bagella, Luigi; De Luca, Antonio; Sartorelli, Vittorio; Giordano, Antonio; Puri, Pier Lorenzo // Oncogene;3/18/2004, Vol. 23 Issue 12, p2177 

    The balance between acetylation and deacetylation of histone and nonhistone proteins controls gene expression in a variety of cellular processes, with transcription being activated by acetyltransferases and silenced by deacetylases. We report here the formation and enzymatic characterization of...

  • Expression of Expanded CAG Transcripts Triggers Nucleolar Stress in Huntington's Disease. Tsoi, Ho; Chan, Ho // Cerebellum;Jun2013, Vol. 12 Issue 3, p310 

    Polyglutamine (polyQ) diseases, including several types of spinocerebellar ataxias and Huntington's disease (HD), are dominantly inherited neurodegenerative disorders caused by the expansion of the glutamine-coding CAG repeat in the open reading frame of the disease gene. Apart from being...

  • The RNA helicase p68 modulates expression and function of the Δ133 isoform(s) of p53, and is inversely associated with Δ133p53 expression in breast cancer. Moore, H C; Jordan, L B; Bray, S E; Baker, L; Quinlan, P R; Purdie, C A; Thompson, A M; Bourdon, J-C; Fuller-Pace, F V // Oncogene;12/9/2010, Vol. 29 Issue 49, p6475 

    The RNA helicase p68 is a potent co-activator of p53-dependent transcription in response to DNA damage. Previous independent studies have indicated that p68 and the Δ133p53 isoforms, which modulate the function of full-length p53, are aberrantly expressed in breast cancers. Here we identify...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics